cardiovascular system
hypertension
(
J:287773
)
• higher systolic and diastolic blood pressure
• hypertension is especially pronounced during the active, awake period
• hydrochlorothiazide (HCTZ) treatment normalizes blood pressure
|
• dietary salt loading exacerbates hypertension
|
renal/urinary system
• mice exhibit lower rates of urinary potassium excretion and are unable to develop a transtubular potassium gradient, indicating impaired potassium secretion from the aldosterone-sensitive distal nephron
• HCTZ restores urinary potassium excretion and transtubular potassium gradient
|
• aldosterone-sensitive distal nephron mass is reduced
• length and area of cortical distal nephron segment DCT1 is increased with a commensurate decrease in the length and area of the CNT segment
• HCTZ treatment reverses the structural nephron remodeling
|
• salt-sensitive hypertension with low rein indicates aberrant gain in renal sodium absorption
|
hematopoietic system
homeostasis/metabolism
• reduction in BUN levels
• HCTZ treatment corrects BUN levels
|
hyperkalemia
(
J:287773
)
• mice exhibit high plasma potassium levels
• a potassium-rich diet exacerbates hyperkalemia
• HCTZ corrects the hyperkalemia
|
• mice exhibit lower rates of urinary potassium excretion and are unable to develop a transtubular potassium gradient, indicating impaired potassium secretion from the aldosterone-sensitive distal nephron
• HCTZ restores urinary potassium excretion and transtubular potassium gradient
|
• plasma renin activity is decreased
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
pseudohypoaldosteronism | DOID:4479 | J:287773 |